Pittenger & Anderson Inc Bristol Myers Squibb CO Transaction History

Pittenger & Anderson Inc

$2.35 Billion
Q2 2024

A detailed history of Pittenger & Anderson Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pittenger & Anderson Inc holds 2,569 shares of BMY stock, worth $136,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,569

Previous 2,569 -0.0%

Holding current value

$136,722

Previous $139,000 23.74%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $49,131 - $55,705	1,024 Added 66.28%	2,569 $139,000
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $92,624 - $103,568	-1,600 Reduced 50.87%	1,545 $89,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $12,742 - $14,147	200 Added 6.79%	3,145 $201,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $27,392 - $32,436	-400 Reduced 11.96%	2,945 $211,000
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $210,876 - $252,859	-3,430 Reduced 50.63%	3,345 $244,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $4.41 Million - $5.14 Million	-82,241 Reduced 92.39%	6,775 $422,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $576,552 - $675,356	-9,744 Reduced 9.87%	89,016 $5.27 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $36,836 - $40,114	595 Added 0.61%	98,760 $6.6 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $142,416 - $160,176	-2,400 Reduced 2.39%	98,165 $6.2 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $41,861 - $47,436	725 Added 0.73%	100,565 $6.24 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $248,212 - $275,052	4,322 Added 4.52%	99,840 $6.02 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $18,858 - $22,046	344 Added 0.36%	95,518 $5.62 Million
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $789,681 - $1.15 Million	17,019 Added 21.78%	95,174 $5.31 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $1.11 Million - $1.45 Million	22,525 Added 40.49%	78,155 $5.02 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $837,008 - $992,394	-19,570 Reduced 26.02%	55,630 $2.82 Million
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $254,333 - $281,238	5,700 Added 8.2%	75,200 $3.41 Million
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $2.62 Million - $3.12 Million	58,000 Added 504.35%	69,500 $3.32 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $97,520 - $126,460	2,000 Added 21.05%	11,500 $598,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $38,948 - $44,837	-650 Reduced 6.4%	9,500 $601,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $36,863 - $40,190	615 Added 6.45%	10,150 $622,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $18,502 - $21,352	335 Added 3.64%	9,535 $608,000
Q2 2017 Aug 10, 2017	BUY	N/A	9,200	9,200 $513,000

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.

Account

Pittenger & Anderson Inc Bristol Myers Squibb CO Transaction History